about
Staphylococcal alpha-phenol soluble modulins contribute to neutrophil lysis after phagocytosis.Structure of the Tyrosine-sulfated C5a Receptor N Terminus in Complex with Chemotaxis Inhibitory Protein of Staphylococcus aureusStructural and functional implications of the alternative complement pathway C3 convertase stabilized by a staphylococcal inhibitorHow microorganisms avoid phagocyte attractionIdentification of an immunomodulating metalloprotease of Pseudomonas aeruginosa (IMPa)Convertase inhibitory properties of Staphylococcal extracellular complement-binding protein.Functional basis for complement evasion by staphylococcal superantigen-like 7.Staphylococcus aureus Staphopain A inhibits CXCR2-dependent neutrophil activation and chemotaxis.A Staphylococcus aureus TIR domain protein virulence factor blocks TLR2-mediated NF-κB signaling.The innate immune modulators staphylococcal complement inhibitor and chemotaxis inhibitory protein of Staphylococcus aureus are located on beta-hemolysin-converting bacteriophages.The role of high density lipoprotein in sepsis.Staphylococcal complement evasion by various convertase-blocking molecules.Staphylococcal innate immune evasion.Complement Factor H Binds to Human Serum Apolipoprotein E and Mediates Complement Regulation on High Density Lipoprotein Particles.Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial antiinflammatory agent.Bacterial complement evasion.Staphylococcus aureus elaborates leukocidin AB to mediate escape from within human neutrophilsRecognition of LPS by TLR4: potential for anti-inflammatory therapies.Serum amyloid P component bound to gram-negative bacteria prevents lipopolysaccharide-mediated classical pathway complement activationResidues 10-18 within the C5a receptor N terminus compose a binding domain for chemotaxis inhibitory protein of Staphylococcus aureus.Staphylococcal SSL5 inhibits leukocyte activation by chemokines and anaphylatoxins.The staphylococcal toxin Panton-Valentine Leukocidin targets human C5a receptors.Serum amyloid P component prevents high-density lipoprotein-mediated neutralization of lipopolysaccharide.Inhibition of Pseudomonas aeruginosa virulence: characterization of the AprA-AprI interface and species selectivity.MprF-mediated lysinylation of phospholipids in Staphylococcus aureus leads to protection against oxygen-independent neutrophil killing.Staphylococcal superantigen-like 10 inhibits CXCL12-induced human tumor cell migration.Effect of human polymorphonuclear and mononuclear leukocytes on chromosomal and plasmid DNA of Escherichia coli. Role of acid DNase.Adjuvant Quil A improves protection in mice and enhances opsonic capacity of antisera induced by pneumococcal polysaccharide conjugate vaccines.A homolog of formyl peptide receptor-like 1 (FPRL1) inhibitor from Staphylococcus aureus (FPRL1 inhibitory protein) that inhibits FPRL1 and FPR.Clumping factor A of Staphylococcus aureus inhibits phagocytosis by human polymorphonuclear leucocytes.A novel flow cytometric assay to quantify soluble CD14 concentration in human serum.Intravital two-photon microscopy of host-pathogen interactions in a mouse model of Staphylococcus aureus skin abscess formation.Pneumococcal immune evasion: ZmpC inhibits neutrophil influx.Staphylococcus aureus strains lacking D-alanine modifications of teichoic acids are highly susceptible to human neutrophil killing and are virulence attenuated in mice.Staphylococcus aureus formyl peptide receptor-like 1 inhibitor (FLIPr) and its homologue FLIPr-like are potent FcγR antagonists that inhibit IgG-mediated effector functions.Lipoprotein metabolism in patients with severe sepsis.Evasion of Toll-like receptor 2 activation by staphylococcal superantigen-like protein 3.Entrapment exploited.The use of a hybridization assay for the study of host defences against herpes simplex virus.A general sequence independent solid phase method for the site specific synthesis of multiple sulfated-tyrosine containing peptides.
P50
Q27314065-7FF4FB13-937F-483E-9C8E-BB16F4B1378CQ27653982-9E24B2E9-C071-4379-9E3E-F1B3D83340FAQ27655786-A8DFC85F-E9D7-470E-90C1-8B75E846CDFCQ28269745-7F083117-7920-437B-AFE7-259E10062577Q28492953-38BC7B18-57BE-49C7-9FCD-795A00C58862Q33832527-5DA71345-7C2C-4D67-97B7-D5F2C0888C69Q34137944-A6B0F554-2EF5-4AF1-8961-CC95DB249228Q34291634-71682288-4EC3-4401-8733-D815DBDA076EQ34345726-DD8F791A-5DF2-4300-9A16-C63D427C83E3Q34353754-CC3F53A2-992F-41B1-873D-B0EF418914D7Q34389050-1D254A61-CB00-4FF5-AE51-7A4FBB885E03Q36228970-563E965F-7BE9-4765-9CA9-7193769ACB86Q36293623-827DA956-7208-440A-8331-09F905CF077BQ36323504-4560A866-A8E7-4591-A731-52858251CC1FQ36403878-BA59AF4D-DCC6-4BA0-A671-8862AD4D75C7Q36550174-8BD66652-3F6D-457C-8221-80E2D7466882Q36826997-730DF0ED-7C01-4F49-B76E-FE3409440264Q38233314-ACC4BDD1-A96E-42EB-82D2-53B5A5C8A4ADQ38314378-72676C3F-58DB-4B83-953D-59CC58A6E2BEQ38334334-7AFD2A07-8399-4E47-A63F-1ED296AA194EQ38359849-3D2EF6F7-5748-4545-BB3F-8C7071B1D014Q39416905-E1DE7AE7-FAB4-4BCC-8A02-1DEC2902300FQ39537763-6FEB6A35-C049-4394-AA26-75DEDCAB2FD6Q39677308-60E6DA1C-991A-4D89-9ACD-70CCC0902040Q39707027-B726BC37-782B-4958-BAE4-EC5B9A3E268EQ39869145-595A51F5-7B29-41B7-9CD0-59ADCD185A17Q40925788-06DD9BFD-4042-4EBC-AA33-DF1BE72F9624Q41432349-8C5080F0-397E-4A45-91BE-266375E5A70AQ43257207-A71ED119-98E8-44D8-9BCE-AB17A36B4445Q43756126-E54D999F-1A72-46F8-B74C-02D6670591FCQ43759363-59396B47-B05B-46C7-818A-FC8357322A64Q43922049-AFC05839-E230-4004-81DF-78CDC3A8C175Q43971573-851BB668-901C-40D5-BFEC-8CFF8AC76403Q44074411-2C34A67B-5C1F-4BC3-A131-98AA41642BA2Q44076378-18685B93-5B1B-4CC6-91A3-5D78FEBA68CCQ44456717-2879F8E4-F4CD-498C-A221-1C2501E9D3D2Q44799814-3339D0D8-18B8-4CED-A0A5-8FD553C9DC6EQ45220601-07F5E020-C16A-4997-AB22-FB968F5647A0Q45844785-7D1495EA-1422-45C6-920F-C907C4305DA7Q46001222-2DE5A007-2701-4DE6-80C9-64E9FBC84359
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Jos A. G. Van Strijp
@ast
Jos A. G. Van Strijp
@en
Jos A. G. Van Strijp
@es
Jos A. G. Van Strijp
@nl
Jos A. G. Van Strijp
@sl
type
label
Jos A. G. Van Strijp
@ast
Jos A. G. Van Strijp
@en
Jos A. G. Van Strijp
@es
Jos A. G. Van Strijp
@nl
Jos A. G. Van Strijp
@sl
prefLabel
Jos A. G. Van Strijp
@ast
Jos A. G. Van Strijp
@en
Jos A. G. Van Strijp
@es
Jos A. G. Van Strijp
@nl
Jos A. G. Van Strijp
@sl
P1053
J-9549-2014
P106
P21
P2798
P31
P496
0000-0001-6253-0830